Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon for Preventive Analgesia in Laparoscopic Cholecystectomy
NCT07566663Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jun 2026
- Primary completion
- May 2028
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hsk21542 in postoperative pain (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Time-weighted sum of pain intensity differences over 0-24 hours postoperatively of visceral pain. Started Jun 2026; status: recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07566663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07566663.